Skip to content

Rapid Diagnosis of Antibiotic Resistance in Gonorrhoea

Rapid Diagnosis of Antibiotic Resistance in Gonorrhoea: RaDAR-Go

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02350907
Acronym
RaDAR-Go
Enrollment
261
Registered
2015-01-30
Start date
2015-02-28
Completion date
2016-08-31
Last updated
2019-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gonorrhoea

Keywords

antimicrobial resistance, point-of-care testing, Neisseria gonorrhoeae

Brief summary

The purpose of this study is to develop a laboratory-based assay that will be a real-time PCR test to detect the organism N. gonorrhoeae and its most important genetic markers of antimicrobial resistance. This study will also determine factors associated with gonorrhoea and describe sexual behaviours of men who have sex with men, to inform parameters for a mathematical model of gonorrhoea transmission and antimicrobial resistant gonorrhoea.

Interventions

None listed

Sponsors

University of Bern
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Participant is willing and able to give informed consent for participation in the study. * Male or female, aged 18 years or above. * Participant is literate in German, French, English or Hungarian. * Participant is at risk for a N. gonorrhoeae infection. This is defined as: 1. exhibiting signs/symptoms of a N. gonorrhoeae infection. 2. having a sexual partner who has been diagnosed with a N. gonorrhoeae infection. 3. participating in high-risk activities for a N. gonorrhoeae infection.

Exclusion criteria

* Subject does not agree to undergo diagnostic test for gonorrhoea.

Design outcomes

Primary

MeasureTime frame
Presence of N. gonorrhoeae genetic markers for antimicrobial resistance in clinical specimensDay of specimen sampling

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026